Sarinnapha M Vasunilashorn1,2, Simon T Dillon1,2, Noel Y Chan1, Tamara G Fong2,3,4, Marie Joseph1, Bridget Tripp5, Zhongcong Xie2,6, Long H Ngo1,2, Chun Geun Lee7, Jack A Elias7, Hasan H Otu5, Sharon K Inouye2,4, Edward R Marcantonio1,2, Towia A Libermann1,2. 1. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 2. Harvard Medical School, Boston, Massachusetts, USA. 3. Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 4. Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA. 5. Department of Electrical and Computer Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, USA. 6. Department of Anesthesia, Massachusetts General Hospital, Boston, Massachusetts, USA. 7. Department of Molecular Microbiology and Immunology, Warren Alpert School of Medicine, Brown University, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Delirium (an acute change in cognition) is a common, morbid, and costly syndrome seen primarily in aging adults. Despite increasing knowledge of its epidemiology, delirium remains a clinical diagnosis with no established biomarkers to guide diagnosis or management. Advances in proteomics now provide opportunities to identify novel markers of risk and disease progression for postoperative delirium and its associated long-term consequences (eg, long-term cognitive decline and Alzheimer's disease [AD]). METHODS: In a nested matched case-control study (18 delirium/no-delirium pairs) within the Successful Aging after Elective Surgery study (N = 556), we evaluated the association of 1305 plasma proteins preoperatively [PREOP] and on postoperative day 2 [POD2]) with delirium using SOMAscan. Generalized linear models were applied to enzyme-linked immunosorbant assay (ELISA) validation data of one protein across the full cohort. Multi-protein modeling included delirium biomarkers identified in prior work (C-reactive protein, interleukin-6 [IL6]). RESULTS: We identified chitinase-3-like-protein-1 (CHI3L1/YKL-40) as the sole delirium-associated protein in both a PREOP and a POD2 predictor model, a finding confirmed by ELISA. Multi-protein modeling found high PREOP CHI3L1/YKL-40 and POD2 IL6 increased the risk of delirium (relative risk [95% confidence interval] Quartile [Q]4 vs Q1: 2.4[1.2-5.0] and 2.1[1.1-4.1], respectively). CONCLUSIONS: Our identification of CHI3L1/YKL-40 in postoperative delirium parallels reports of CHI3L1/YKL-40 and its association with aging, mortality, and age-related conditions including AD onset and progression. This highlights the type 2 innate immune response, involving CHI3L1/YKL-40, as an underlying mechanism of postoperative delirium, a common, morbid, and costly syndrome that threatens the independence of older adults.
BACKGROUND: Delirium (an acute change in cognition) is a common, morbid, and costly syndrome seen primarily in aging adults. Despite increasing knowledge of its epidemiology, delirium remains a clinical diagnosis with no established biomarkers to guide diagnosis or management. Advances in proteomics now provide opportunities to identify novel markers of risk and disease progression for postoperative delirium and its associated long-term consequences (eg, long-term cognitive decline and Alzheimer's disease [AD]). METHODS: In a nested matched case-control study (18 delirium/no-delirium pairs) within the Successful Aging after Elective Surgery study (N = 556), we evaluated the association of 1305 plasma proteins preoperatively [PREOP] and on postoperative day 2 [POD2]) with delirium using SOMAscan. Generalized linear models were applied to enzyme-linked immunosorbant assay (ELISA) validation data of one protein across the full cohort. Multi-protein modeling included delirium biomarkers identified in prior work (C-reactive protein, interleukin-6 [IL6]). RESULTS: We identified chitinase-3-like-protein-1 (CHI3L1/YKL-40) as the sole delirium-associated protein in both a PREOP and a POD2 predictor model, a finding confirmed by ELISA. Multi-protein modeling found high PREOP CHI3L1/YKL-40 and POD2 IL6 increased the risk of delirium (relative risk [95% confidence interval] Quartile [Q]4 vs Q1: 2.4[1.2-5.0] and 2.1[1.1-4.1], respectively). CONCLUSIONS: Our identification of CHI3L1/YKL-40 in postoperative delirium parallels reports of CHI3L1/YKL-40 and its association with aging, mortality, and age-related conditions including AD onset and progression. This highlights the type 2 innate immune response, involving CHI3L1/YKL-40, as an underlying mechanism of postoperative delirium, a common, morbid, and costly syndrome that threatens the independence of older adults.
Authors: Chun Geun Lee; Charles S Dela Cruz; Erica Herzog; Stephen M Rosenberg; Farida Ahangari; Jack A Elias Journal: Am J Respir Crit Care Med Date: 2012-04-01 Impact factor: 21.405
Authors: Sharon K Inouye; Edward R Marcantonio; Cyrus M Kosar; Douglas Tommet; Eva M Schmitt; Thomas G Travison; Jane S Saczynski; Long H Ngo; David C Alsop; Richard N Jones Journal: Alzheimers Dement Date: 2016-04-18 Impact factor: 21.566
Authors: Sarinnapha M Vasunilashorn; Long H Ngo; Noel Y Chan; Wenxiao Zhou; Simon T Dillon; Hasan H Otu; Sharon K Inouye; Iris Wyrobnik; George A Kuchel; Janet E McElhaney; Zhongcong Xie; David C Alsop; Richard N Jones; Towia A Libermann; Edward R Marcantonio Journal: J Gerontol A Biol Sci Med Sci Date: 2019-01-16 Impact factor: 6.053
Authors: Jane S Saczynski; Cyrus M Kosar; Guoquan Xu; Margaret R Puelle; Eva Schmitt; Richard N Jones; Edward R Marcantonio; Bonnie Wong; Ilean Isaza; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2014-02-10 Impact factor: 5.562
Authors: Eva M Schmitt; Jane S Saczynski; Cyrus M Kosar; Edward R Marcantonio; Thomas Travison; Sharon K Inouye; Richard N Jones; David C Alsop; Tamara G Fong; Eran Metzger; Zara Cooper Journal: J Am Geriatr Soc Date: 2015-12-14 Impact factor: 5.562
Authors: T G Fong; R N Jones; P Shi; E R Marcantonio; L Yap; J L Rudolph; F M Yang; D K Kiely; S K Inouye Journal: Neurology Date: 2009-05-05 Impact factor: 9.910
Authors: Yetrib Hathout; Edward Brody; Paula R Clemens; Linda Cripe; Robert Kirk DeLisle; Pat Furlong; Heather Gordish-Dressman; Lauren Hache; Erik Henricson; Eric P Hoffman; Yvonne Monique Kobayashi; Angela Lorts; Jean K Mah; Craig McDonald; Bob Mehler; Sally Nelson; Malti Nikrad; Britta Singer; Fintan Steele; David Sterling; H Lee Sweeney; Steve Williams; Larry Gold Journal: Proc Natl Acad Sci U S A Date: 2015-05-26 Impact factor: 11.205
Authors: Daniel A Muruve; Hanna Debiec; Simon T Dillon; Xuesong Gu; Emmanuelle Plaisier; Handan Can; Hasan H Otu; Towia A Libermann; Pierre Ronco Journal: Kidney Int Rep Date: 2022-04-14